你好,请登录   免费注册    |    收藏本站
联系电话: 0574-87917803
联系电话: call_new 0574-87917803
NCI-H522 [H522]
NCI-H522 [H522]
规格:
货期:
编号:TS211263
品牌:Testobio
产品名称: NCI-H522 H522
商品货号: TS211263
Organism: Homo sapiens, human
Tissue: lung
Product Format: frozen
Morphology: epithelial
Culture Properties: adherent, single cells and loosely attached clusters
Biosafety Level: 1

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Disease: stage 2,adenocarcinoma; non-small cell lung cancer
Age: 58 years
Gender: male
Ethnicity: Caucasian
Storage Conditions: liquid nitrogen vapor phase
Karyotype: modal number = 53. This is a hypotriploid human cell line with the modal chromosome number occurring in 68% of cells counted. The polyploid cells occurred at 3.0%; eleven marker chromosomes were common to all cells, of which two were paired. The markers included: der(6)(q13), t(7p17q), del(10)(p11.23), paired der(7)t(7;?17)(p22;?q21.1) and der(16)t(16;?)(q24;?), and six others; normal Y, N13, N15, and N16 were absent; the X chromosomes were mostly paired.
Derivation:
This line was derived by A.F. Gazdar, H.K. Oie, J.D. Minna and associates from a lung cancer obtained from a patient prior to therapy.xad
Clinical Data:
58 years
Caucasian
male
The patient was a smoker (60-pack-year).

Comments:

The cells carry a mutation in codon 191 of the TP53 gene.

The cells are not able to synthesize the peptide neuromedin B (NMB) or the gastrin releasing peptide (GRP).

The cells stain positive for keratin and vimentin but are negative for neurofilament triplet protein.

Complete Growth Medium: The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, ATCC 30-2001. To make the complete growth medium, add the following components to the base medium: fetal bovine serum (ATCC 30-2020) to a final concentration of 10%.
Subculturing:

Remove medium, and rinse with 0.25% trypsin, 0.53 mM EDTA solution. Remove the solution and add an additional 1 to 2 mL of trypsin-EDTA solution. Allow the flask to sit at room temperature (or at 37°C) until the cells detach. Add fresh culture medium, aspirate and dispense into new culture flasks.

Subcultivation Ratio: A subcultivation ratio of 1:3 to 1:6 is recommended
Medium Renewal: Every 2 to 3 days
Cryopreservation:
Freeze medium: Complete growth medium supplemented with 5% (v/v) DMSO
Storage temperature: liquid nitrogen vapor phase
STR Profile:
Amelogenin: X
CSF1PO: 10
D13S317: 10
D16S539: 12
D5S818: 11
D7S820: 9,10
THO1: 7,9.3
TPOX: 9,10
vWA: 17
Name of Depositor: AF Gazdar, JD Minna
Deposited As: Homo sapiens
References:

Banks-Schlegel SP, et al. Intermediate filament and cross-linked envelope expression in human lung tumor cell lines. Cancer Res. 45: 1187-1197, 1985. PubMed: 2578876

Mitsudomi T, et al. p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features. Oncogene 7: 171-180, 1992. PubMed: 1311061

Giaccone G, et al. Neuromedin B is present in lung cancer cell lines. Cancer Res. 52: 2732s-2736s, 1992. PubMed: 1563005

NCI-Navy Medical Oncology Branch Cell Line Supplement. J. Cell. Biochem. suppl. 24: 1996.

首页 > 产品中心 > 微生物培养 > 菌株 > null > NCI-H522 [H522]

NCI-H522 [H522]

  • 货号: TS211263
  • 好评
询价
  • 品牌 : TESTOBIO
产品名称: NCI-H522 H522
商品货号: TS211263
Organism: Homo sapiens, human
Tissue: lung
Product Format: frozen
Morphology: epithelial
Culture Properties: adherent, single cells and loosely attached clusters
Biosafety Level: 1

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Disease: stage 2,adenocarcinoma; non-small cell lung cancer
Age: 58 years
Gender: male
Ethnicity: Caucasian
Storage Conditions: liquid nitrogen vapor phase
Karyotype: modal number = 53. This is a hypotriploid human cell line with the modal chromosome number occurring in 68% of cells counted. The polyploid cells occurred at 3.0%; eleven marker chromosomes were common to all cells, of which two were paired. The markers included: der(6)(q13), t(7p17q), del(10)(p11.23), paired der(7)t(7;?17)(p22;?q21.1) and der(16)t(16;?)(q24;?), and six others; normal Y, N13, N15, and N16 were absent; the X chromosomes were mostly paired.
Derivation:
This line was derived by A.F. Gazdar, H.K. Oie, J.D. Minna and associates from a lung cancer obtained from a patient prior to therapy.xad
Clinical Data:
58 years
Caucasian
male
The patient was a smoker (60-pack-year).

Comments:

The cells carry a mutation in codon 191 of the TP53 gene.

The cells are not able to synthesize the peptide neuromedin B (NMB) or the gastrin releasing peptide (GRP).

The cells stain positive for keratin and vimentin but are negative for neurofilament triplet protein.

Complete Growth Medium: The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, ATCC 30-2001. To make the complete growth medium, add the following components to the base medium: fetal bovine serum (ATCC 30-2020) to a final concentration of 10%.
Subculturing:

Remove medium, and rinse with 0.25% trypsin, 0.53 mM EDTA solution. Remove the solution and add an additional 1 to 2 mL of trypsin-EDTA solution. Allow the flask to sit at room temperature (or at 37°C) until the cells detach. Add fresh culture medium, aspirate and dispense into new culture flasks.

Subcultivation Ratio: A subcultivation ratio of 1:3 to 1:6 is recommended
Medium Renewal: Every 2 to 3 days
Cryopreservation:
Freeze medium: Complete growth medium supplemented with 5% (v/v) DMSO
Storage temperature: liquid nitrogen vapor phase
STR Profile:
Amelogenin: X
CSF1PO: 10
D13S317: 10
D16S539: 12
D5S818: 11
D7S820: 9,10
THO1: 7,9.3
TPOX: 9,10
vWA: 17
Name of Depositor: AF Gazdar, JD Minna
Deposited As: Homo sapiens
References:

Banks-Schlegel SP, et al. Intermediate filament and cross-linked envelope expression in human lung tumor cell lines. Cancer Res. 45: 1187-1197, 1985. PubMed: 2578876

Mitsudomi T, et al. p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features. Oncogene 7: 171-180, 1992. PubMed: 1311061

Giaccone G, et al. Neuromedin B is present in lung cancer cell lines. Cancer Res. 52: 2732s-2736s, 1992. PubMed: 1563005

NCI-Navy Medical Oncology Branch Cell Line Supplement. J. Cell. Biochem. suppl. 24: 1996.

合作单位: